# Correction to: SRRM2 may be a potential biomarker and immunotherapy target for multiple myeloma: a real-world study based on flow cytometry detection

**Authors:** Jinjing Guo, Zhiye Zhang, Huiping Wang, Qian Li, Mengmeng Fan, Wanqiu Zhang, Qianshan Tao, Zhitao Wang, Chun Ling, Hao Xiao, Zhimai Gao, Zhimin Zhai

PMC · DOI: 10.1007/s10238-024-01393-1 · 2024-07-18

## Full-text entities

- **Genes:** SRRM2 (serine/arginine repetitive matrix 2) [NCBI Gene 23524] {aka 300-KD, CWF21, Cwc21, HSPC075, MRD72, SRL300}
- **Diseases:** multiple myeloma (MESH:D009101)

---
Source: https://tomesphere.com/paper/PMC11258154